Clinical Trial 40909


Chesterfield, MO 63005

Study Summary:

The purpose of this study is to understand whether the drug, pimavanserin, improves symptoms of hallucinations and/or delusions experienced in people with dementia. 

Qualified Participants Must:

• Have been diagnosed with dementia, dementia with Lewy bodies (DLB), Parkinson's disease dementia (PPD), Alzheimer's disease, frontotemporal degeneration, or vascular dementia
• Have experienced hallucinations (seeing, hearing, or otherwise sensing things that aren't there) and/or delusions (false or mitaken beliefs) for at least 2 months
• Be between 50 and 90 years of age
• Have a study partner who is able to attend study visits

Qualified Participants May Receive:

All participants will be given pimavanserin in the first part of the study. If their hallucinations or delusions improve, participants may qualify for the second part of the study; Compensation is available for time and travel

Study is Available At:

Clinical Research Professionals
17998 Chesterfield Airport Rd., Suite 100
Chesterfield, MO 63005
View Clinic Location


If you or someone you care for is interested in participating in this clinical trial and lives within 100 miles of the clinic, please complete the form below and click 'I Am Interested In This Study'

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.